[Translation] A randomized, controlled, open-label, multicenter, phase II/III clinical study to evaluate the safety and efficacy of chlorogenic acid for injection in the treatment of recurrent grade IV glioblastoma (GBM)
评估注射用绿原酸治疗复发GBM患者的总生存期OS非劣于洛莫司汀单药组
[Translation] To evaluate the non-inferiority of OS in patients with relapsed GBM treated with chlorogenic acid for injection compared with lomustine monotherapy group